Rokos Capital Management LLP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rokos Capital Management LLP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$44,311,596
-21.5%
1,389,2960.0%0.32%
-41.1%
Q2 2023$56,474,882
+9.4%
1,389,2960.0%0.55%
-85.7%
Q1 2023$51,605,400
+81.8%
1,389,296
+68.2%
3.82%
+206.8%
Q4 2022$28,391,785
+69.8%
826,063
+184.3%
1.24%
+149.8%
Q3 2022$16,723,000
-0.7%
290,528
-12.6%
0.50%
+1.0%
Q2 2022$16,839,000
+108.3%
332,384
+198.1%
0.49%
+30.4%
Q1 2022$8,084,000111,5150.38%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders